FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079747892> ?p ?o ?g. }

• W2079747892 endingPage "542.e2" @default.
• W2079747892 startingPage "534" @default.
• W2079747892 abstract "To calculate the incidence rates of ocular complications and vision loss in HLA-B27-associated uveitis and to explore the effect of chronic inflammation on clinical outcomes.Retrospective longitudinal cohort study.The clinical records of 99 patients (148 uveitis-affected eyes) with HLA-B27-associated uveitis seen at a tertiary care center were included. The main outcome measures were ocular complications (posterior iris synechiae, band keratopathy, posterior subcapsular [PSC] cataracts, ocular hypertension, hypotony, cystoid macular edema, and epiretinal membrane) and vision loss. Anterior chamber inflammation was defined as ≥1+ grade inflammation. Chronic uveitis was defined as persistent inflammation with relapse in <3 months after discontinuing treatment or requiring medications to suppress inflammation for >3 months after reviewing the patient's entire clinical course.The clinical course was most commonly acute/recurrent (75%) or chronic (20%). The most common complications to develop during follow-up were ocular hypertension (0.10/eye-year) and PSC cataracts (0.09/eye-year). In multivariate analysis, the presence of posterior synechiae at presentation, inflammation, corticosteroid-sparing therapy, corticosteroid injections, chronic disease, and male gender were associated with a statistically significant increased risk of developing vision loss (20/50 or worse). Chronic disease course was associated with a 7-fold increased risk of visual impairment (hazard ratio [HR] = 6.8, P < .0001). The presence of inflammation during follow-up was associated with an increased risk of developing visual impairment (HR = 6.2, P < .0001). In multivariate analysis, chronic disease course and topical corticosteroids were associated with an increased risk of developing any incident ocular complication (HR = 2.2, P = .04 and HR = 3.3, P = .01, respectively).Poorly controlled inflammation was associated with the development of ocular complications including vision loss. Patients with chronic inflammation were also at greater risk of complications." @default.
• W2079747892 created "2016-06-24" @default.
• W2079747892 creator A5005774191 @default.
• W2079747892 creator A5091117608 @default.
• W2079747892 date "2010-10-01" @default.
• W2079747892 modified "2023-10-06" @default.
• W2079747892 title "Incidence Rates and Risk Factors for Ocular Complications and Vision Loss in HLA-B27-Associated Uveitis" @default.
• W2079747892 cites W1972752703 @default.
• W2079747892 cites W1978626400 @default.
• W2079747892 cites W1980152514 @default.
• W2079747892 cites W1994005219 @default.
• W2079747892 cites W1996117162 @default.
• W2079747892 cites W2002210913 @default.
• W2079747892 cites W2011101904 @default.
• W2079747892 cites W2032998731 @default.
• W2079747892 cites W2034141004 @default.
• W2079747892 cites W2044423815 @default.
• W2079747892 cites W2060721487 @default.
• W2079747892 cites W2064325706 @default.
• W2079747892 cites W2072664035 @default.
• W2079747892 cites W2082651867 @default.
• W2079747892 cites W2083970208 @default.
• W2079747892 cites W2084189709 @default.
• W2079747892 cites W2092413492 @default.
• W2079747892 cites W2100774140 @default.
• W2079747892 cites W2101084509 @default.
• W2079747892 cites W2108832576 @default.
• W2079747892 cites W2112901522 @default.
• W2079747892 cites W2139499737 @default.
• W2079747892 cites W2140309296 @default.
• W2079747892 cites W2142555697 @default.
• W2079747892 cites W4210976270 @default.
• W2079747892 doi "https://doi.org/10.1016/j.ajo.2010.04.031" @default.
• W2079747892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2945450" @default.
• W2079747892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20643395" @default.
• W2079747892 hasPublicationYear "2010" @default.
• W2079747892 type Work @default.
• W2079747892 sameAs 2079747892 @default.
• W2079747892 citedByCount "70" @default.
• W2079747892 countsByYear W20797478922012 @default.
• W2079747892 countsByYear W20797478922013 @default.
• W2079747892 countsByYear W20797478922014 @default.
• W2079747892 countsByYear W20797478922015 @default.
• W2079747892 countsByYear W20797478922016 @default.
• W2079747892 countsByYear W20797478922017 @default.
• W2079747892 countsByYear W20797478922018 @default.
• W2079747892 countsByYear W20797478922019 @default.
• W2079747892 countsByYear W20797478922020 @default.
• W2079747892 countsByYear W20797478922021 @default.
• W2079747892 countsByYear W20797478922022 @default.
• W2079747892 countsByYear W20797478922023 @default.
• W2079747892 crossrefType "journal-article" @default.
• W2079747892 hasAuthorship W2079747892A5005774191 @default.
• W2079747892 hasAuthorship W2079747892A5091117608 @default.
• W2079747892 hasBestOaLocation W20797478922 @default.
• W2079747892 hasConcept C118487528 @default.
• W2079747892 hasConcept C120665830 @default.
• W2079747892 hasConcept C121332964 @default.
• W2079747892 hasConcept C126322002 @default.
• W2079747892 hasConcept C141071460 @default.
• W2079747892 hasConcept C167135981 @default.
• W2079747892 hasConcept C207103383 @default.
• W2079747892 hasConcept C2776194053 @default.
• W2079747892 hasConcept C2778257484 @default.
• W2079747892 hasConcept C2780225610 @default.
• W2079747892 hasConcept C2780347916 @default.
• W2079747892 hasConcept C2781242345 @default.
• W2079747892 hasConcept C2781325737 @default.
• W2079747892 hasConcept C44249647 @default.
• W2079747892 hasConcept C61511704 @default.
• W2079747892 hasConcept C71924100 @default.
• W2079747892 hasConceptScore W2079747892C118487528 @default.
• W2079747892 hasConceptScore W2079747892C120665830 @default.
• W2079747892 hasConceptScore W2079747892C121332964 @default.
• W2079747892 hasConceptScore W2079747892C126322002 @default.
• W2079747892 hasConceptScore W2079747892C141071460 @default.
• W2079747892 hasConceptScore W2079747892C167135981 @default.
• W2079747892 hasConceptScore W2079747892C207103383 @default.
• W2079747892 hasConceptScore W2079747892C2776194053 @default.
• W2079747892 hasConceptScore W2079747892C2778257484 @default.
• W2079747892 hasConceptScore W2079747892C2780225610 @default.
• W2079747892 hasConceptScore W2079747892C2780347916 @default.
• W2079747892 hasConceptScore W2079747892C2781242345 @default.
• W2079747892 hasConceptScore W2079747892C2781325737 @default.
• W2079747892 hasConceptScore W2079747892C44249647 @default.
• W2079747892 hasConceptScore W2079747892C61511704 @default.
• W2079747892 hasConceptScore W2079747892C71924100 @default.
• W2079747892 hasFunder F4320306134 @default.
• W2079747892 hasFunder F4320337350 @default.
• W2079747892 hasIssue "4" @default.
• W2079747892 hasLocation W20797478921 @default.
• W2079747892 hasLocation W20797478922 @default.
• W2079747892 hasLocation W20797478923 @default.
• W2079747892 hasLocation W20797478924 @default.
• W2079747892 hasOpenAccess W2079747892 @default.
• W2079747892 hasPrimaryLocation W20797478921 @default.
• W2079747892 hasRelatedWork W116875901 @default.
• W2079747892 hasRelatedWork W1997957340 @default.

• next